December 20, 2017
FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
The U.S. Food and Drug Administration has approved Spark Therapeutics’s Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult…